BAG3 Directly Interacts with Mutated alphaB-Crystallin to Suppress Its Aggregation and Toxicity

Akinori Hishiya*, Mortada Najem Salman, Serena Carra, Harm H. Kampinga, Shinichi Takayama

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    55 Citations (Scopus)
    175 Downloads (Pure)

    Abstract

    A homozygous disruption or genetic mutation of the bag3 gene causes progressive myofibrillar myopathy in mouse and human skeletal and cardiac muscle disorder while mutations in the small heat shock protein aB-crystallin gene ( CRYAB) are reported to be responsible for myofibrillar myopathy. Here, we demonstrate that BAG3 directly binds to wild-type alpha B-crystallin and the alpha B-crystallin mutant R120G, via the intermediate domain of BAG3. Peptides that inhibit this interaction in an in vitro binding assay indicate that two conserved Ile-Pro-Val regions of BAG3 are involved in the interaction with alpha B-crystallin, which is similar to results showing BAG3 binding to HspB8 and HspB6. BAG3 overexpression increased alpha B-crystallin R120G solubility and inhibited its intracellular aggregation in HEK293 cells. BAG3 suppressed cell death induced by alpha B-crystallin R120G overexpression in differentiating C2C12 mouse myoblast cells. Our findings indicate a novel function for BAG3 in inhibiting protein aggregation caused by the genetic mutation of CRYAB responsible for human myofibrillar myopathy.

    Original languageEnglish
    Article number16828
    Number of pages8
    JournalPLoS ONE
    Volume6
    Issue number3
    DOIs
    Publication statusPublished - 15-Mar-2011

    Keywords

    • DESMIN-RELATED MYOPATHY
    • B-CRYSTALLIN
    • MYOFIBRILLAR MYOPATHY
    • CHAPERONE ACTIVITY
    • CELL-DEATH
    • CARDIOMYOPATHY
    • COMPLEX
    • PROTEIN
    • MICE
    • R120G-ALPHA-B-CRYSTALLIN

    Cite this